May 7, 2007 - MINRAD International Inc. announced it has received approval from the FDA to market Sojourn (Sevoflurane) inhalation anesthetic.
MINRAD International, Inc. is an interventional pain management company with real-time image guidance and anesthesia and analgesia product lines. The real-time image guidance products facilitate minimally invasive surgery especially for pain management and have broad applications in orthopedics, neurosurgery, and interventional radiology. These devices enable medical professionals to improve the accuracy of interventional procedures and reduce radiation exposure.